HomeMEDTRONIC plcMedtronic Launches New Solutions to Help Monitor Patients for COVID-19

Medtronic Launches New Solutions to Help Monitor Patients for COVID-19

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its Medtronic Care Management Services (MCMS) business is launching two new solutions designed to help assess, monitor, and triage support for patients who may be concerned about COVID-19 and their respiratory symptoms. It has already launched its new Respiratory Infectious Disease Health Check to existing MCMS customers, and it is now launching a new COVID-19 Virtual Care Evaluation and Monitoring solution available to U.S. health systems, health plans and employers.

“With the rapid spread of COVID-19, we know that alternative approaches to screening, disease monitoring, and patient education are urgently needed to reduce additional population exposure to the virus and ease the burden on health care providers and facilities. It’s easy to understand why staying in self-quarantine and monitoring your own symptoms is challenging. Unless you consult a medical professional, it’s hard to know when your symptoms warrant seeking medical care,” said Sheri Dodd, vice president and general manager of MCMS. “Using technology for self-reported symptom monitoring may play an important role in slowing the spread of the disease and helping escalate patient needs to their provider when appropriate.”

The Respiratory Infectious Disease Health Check for existing MCMS customers is an included add-on to all current care management programs. The Respiratory Infectious Disease Health Check helps patients with chronic, co-morbid health conditions who are at the highest risk for complications or mortality associated with COVID-19 track their respiratory infectious disease symptoms and body temperature through daily health checks. The program reacts dynamically during the health check to present symptom questions based on the patient’s previous responses, and provides patient education to encourage and support self-care. Data is aggregated for clinician review and action if additional intervention is needed.

For health systems, health plans and other employers new to MCMS programs, the company is launching a stand-alone assessment and monitoring service. The COVID-19 Virtual Care Evaluation and Monitoring solution uses a virtual assistant to evaluate patients through a Centers for Disease Control and Prevention (CDC) guideline-based survey for COVID-19 symptoms. If the user’s symptoms warrant it, the solution connects them to the MCMS nurse command center, where registered nurses review the patient’s data and either identify recommendations or the need for additional care assessment, based on the CDC guidelines. This could include a recommendation to continue monitoring symptoms at home, or to contact a healthcare provider directly.

“True to the Medtronic Mission, the health and safety of our customers, their patients, and our employees remains our highest priority as we address this unprecedented outbreak,” says John Liddicoat, M.D., executive vice president and president, Medtronic Americas Region. “Around the world, we are in ongoing communication with customers, suppliers, and governments to prioritize needs to the best of our ability. These solutions aim to help manage unnecessary exposures, minimize burden on the health care system, and escalate the most seriously ill patients for immediate care.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy